Právní předpis byl sestaven k datu 18.04.2024.
Zobrazené znění právního předpisu je účinné od 24.11.2011.
Sdělení o antigenním složení očkovacích látek pro pravidelná, zvláštní a mimořádná očkování pro rok 2012
325/2011 Sb.
325
SDĚLENÍ
Xxxxxxxxxxxx zdravotnictví
xx xxx 1. xxxxxxxxx 2011
x antigenním xxxxxxx xxxxxxxxxx xxxxx xxx xxxxxxxxxx, zvláštní x xxxxxxxxx xxxxxxxx xxx xxx 2012
Ministerstvo xxxxxxxxxxxxx xxxxx §80 xxxx. 1 xxxx. e) xxxxxx č. 258/2000 Xx., x xxxxxxx xxxxxxxxx xxxxxx x x xxxxx xxxxxxxxx xxxxxxxxxxxxx xxxxxx, ve xxxxx zákona x. 298/2011 Xx., xxxxxxx xx xxxxxxx xxxxxxxxxx Xxxxxxx xxxxxxxxxx xxxxxx xxxxxxxxx xxxxxxx očkovacích xxxxx xxx xxxxxxxxxx, xxxxxxxx x mimořádná xxxxxxxx xxx rok 2012:
1. Xxxxxxxxx xxxxxxx očkovacích xxxxx xxx xxxxxxxxxx xxxxxxxx
1x) xxxxxxxxxxx xxxxxxxx xxxxx proti xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), tetanu, dětské xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx), xxxxxx xxxxxxxxxx X, xxxxxxx xxxxxxxxx Xxxxxxxxxxx influenzae xxx x (DTaPHibVHBIPV):
Xxxxxxxxx xxxxxxxxxx
Xxxxxxxxx haemagglutinum xxxxxxxxxxxx
Xxxxxxxxx xxxxxxxxx xxxxxxxx xxxxxxxxx
Xxxxxxxxxxx xxxxxxxxxx
Tetani xxxxxxxxxx xxx.
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx B xxxxxxxxxxxxxx
Xxxxx poliomyelitidis inactivatum xxxxx 1
Xxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx xxxxx 2
Xxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx typus 3
Xxxxxxxxxx Xxx: Polyribosylribitoli xxxxxxxx Xxxxxxxxxxx xxxxxxxxxx x, Xxxxxx xxxxxxxxxx
1x) očkovací látka xxxxx záškrtu, dávivému xxxxx (acelulární forma), xxxxxx (XXxX):
Xxxxxxxxxxx xxxxxxxxxx ≥ 30 xxxxxxxxxxxxx xxxxxxxx
Tetani xxxxxxxxxx ≥ 40 xxxxxxxxxxxxx jednotek
Xxxxxxxxx xxxxxxxxxx (XX) 25 xxxxxxxxxx
Pertussis xxxxxxxxxxxxxxx xxxxxxxxxxxx (XXX) 25 xxxxxxxxxx
Xxxxxxxxxxx (69xX) 8 xxxxxxxxxx
1x) xxxxxxxx xxxxx xxxxx xxxxxxx, dávivému xxxxx (xxxxxxxxxx xxxxx), tetanu, xxxxxxx xxxxxxxxx Xxxxxxxxx xxxxxxxxxx b (XXxXXxx):
Xxxxxxxxxxx xxxxxxxxxx | xxx. 30 mezinárodních xxxxxxxx |
Xxxxxx xxxxxxxxxx | xxx. 40 xxxxxxxxxxxxx jednotek |
Xxxxxxxxx xxxxxxxxxx (XX) | 25 mikrogramů |
Pertussis xxxxxxxxxxxxxxx filamentosum | (FHA) 25 xxxxxxxxxx |
Xxxxxxxxxxx (69xX) | 8 xxxxxxxxxx |
Xxxxxxxxxxx xxxxxxxxxx X | 10 xxxxxxxxxx |
xxx xxxxxxxxx tetanico | 20-40 xxxxxxxxxx |
1d) xxxxxxxx xxxxx xxxxx záškrtu x xxxxxx - xxxxxxxxx:
Xxxxxxxxxx xxxxxxxxxxx xxxxxxxxxxx .................. xxx. 30 mezinárodních xxxxxxxx
Xxxxxxxxxx tetani xxxxxxxxxxx ........................... xxx. 40 xxxxxxxxxxxxx xxxxxxxx
1e) xxxxxxxx látka proti xxxxxxx vyvolaným Xxxxxxxxxxx xxxxxxxxxx xxx b:
1 xxxxx xxxxxxxxxxxxx xxxxxxx xxxxxxxx: Xxxxxxxxxxxxxxx Xxx xxxxxxxxxxx (10 xxxxxxxxxx) cum Xxxxxxxxx xxxxxxxx (30 xxxxxxxxxx).
1x) xxxxxxxx xxxxx xxxxx xxxxxx:
Xxxxxx xxxxxxxxxx ............................................. xxx. 40 mezinárodních xxxxxxxx
1x) xxxxxxxx xxxxx xxxxx virové xxxxxxxxxx X x dětské xxxxxxx:
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx B
1h) xxxxxxxx xxxxx proti xxxxxx xxxxxxxxxx X x xxxxxxx xxxxxxx:
Xxxxxxxxx xxxxxxxxx hepatitidis X
1ch) očkovací xxxxx proti xxxxxxxxxx, xxxxxxxxxx a zarděnkám:
Xxxxxxxxxxx virus xxxxxxxxxx (Xxxxxxx) xxx. 103,0 xxxxxxxx xxxxx xxx xxxxxxxx xxxxxxx50 Parotitidis xxxxx xxxxxxxxxx (XXX 4385) xxx. 103,7 xxxxxxxx xxxxx xxx xxxxxxxx xxxxxxx50 Rubeolae xxxxx attenuatum (Wistar XX 27/3) xxx. 103,0 infekční xxxxx xxx xxxxxxxx xxxxxxx50
1x) xxxxxxxx látka xxxxx dětské xxxxxxxx xxxxx x xxxxxxxxxxxx xxxxx:
Xxxxx poliomyelitis xxxxxxxxxxx typus 1 (Xxxxxxx) ..... 40 xxxxxxxxxxx D xxxxxxxx*
Xxxxx poliomyelitis xxxxxxxxxxx xxxxx 2 (MEF-1) .......... 8 xxxxxxxxxxx X xxxxxxxx*
Xxxxx xxxxxxxxxxxxx inactivatum xxxxx 3 (Saukett) ...... 32 xxxxxxxxxxx X xxxxxxxx*
* xxxx xxxxxxxx xxxxxxxxxxxxxx antigenů xxxxxxxxx xxxxxx xxxxxx xxxxxxxxxxxxx xxxxxx.
1x) xxxxxxxx látka proti xxxxxxx xxxxxxxxx Xxxxxxxxxxxxx xxxxxxxxxx x xxxxxxxxxxxxxxx xxxxxxx:
Xxxxxxxxxxxxxxx Xxxxxxxxxxxx xxxxxxxxxx xxxxx:
1, 2, 3, 4, 5, 6X, 7F, 8, 9X, 9V, 1XX, 11 X, 12X, 14, 15B, 17X,
18X, 19X, 19X, 20, 22X, 23X, 33F ................ 25 xxxxxxxxxx x xxxxxxx sérotypu
1k) xxxxxxxx xxxxx xxxxxxxxxxx xxxxx xxxxxxxxxxxxx xxxxxxxx:
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 1
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 3
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 4
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 5
Pneumococcale xxxxxxxxxxxxxxx xxxxxxxxx 6A
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 6X
Xxxxxxxxxxxxx polysaccharidum sérotypus 7X
Pneumococcale xxxxxxxxxxxxxxx xxxxxxxxx 9V
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 14
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 18X
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 19X
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 19X
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 23X
1la) očkovací xxxxx xxxxx xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), xxxxxx, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx):
Diphtheriae xxxxxxxxxx xx méně xxx 2 xxxxxxxxxxx xxxxxxxx
Xxxxxx xxxxxxxxxx xx xxxx xxx 20 xxxxxxxxxxxxx xxxxxxxx
Xxxxxxxxx xxxxxxxx:
Xxxxxxxxx xxxxxxxxxx .......... 8 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxxx 8 xxxxxxxxxx
Xxxxxxxxx .................... 2,5 xxxxxxxxxx
Xxxxx poliomyelitidis xxxxxxxxxxx:
xxxxx 1 (kmen Xxxxxxx) .... 40 X xxxxxxxx xxxxxxxx
xxxxx 2 (xxxx XXX-1) ......... 8 X xxxxxxxx antigenu
xxxxx 3 (xxxx Xxxxxxx) ...... 32 X xxxxxxxx xxxxxxxx
XXXX
1xx) xxxxxxxx xxxxx proti xxxxxxx, xxxxxxxx kašli (xxxxxxxxxx xxxxx), tetanu, dětské xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx):
Xxxxxxxxxx xxxxxx | xxxx xxxx xxxxx 2 mezinárodní xxxxxxxx (2 Lf) | ||
Tetanický xxxxxx | xxxx xxxx xxxxx 20 mezinárodních xxxxxxxx (5 Xx) | ||
Xxxxxxxxx xxxxxxxx: | |||
Xxxxxxxxx toxoid | 2,5 mikrogramu | ||
Xxxxxxxxxxxx hemaglutinin | 5 xxxxxxxxxx | ||
Fimbrie xxxx 2+3 | 5 xxxxxxxxxx | ||
Xxxxxxxxx | 3 mikrogramy | ||
Virus xxxxxxxxxxxxx xxxx 1 (xxxxxxxxxxxx) | 40 xxxxxxxxxxx X xxxxxxxx | ||
Xxxxx xxxxxxxxxxxxx typu 2 (xxxxxxxxxxxx) | 8 xxxxxxxxxxx X jednotek | ||
Xxxxx xxxxxxxxxxxxx typu 3 (xxxxxxxxxxxx) | 32 xxxxxxxxxxx X jednotek | ||
1m) xxxxxxxx xxxxx proti xxxxxxxxxxx:
Xxxxxxxx Xxxxxxxx Xxxxxx (xxxxxxxxxx) 100&xxxx;000 - 300&xxxx;000 V.U.* (xxxx Copenhagen 1331)
*X.X. = živé xxxxxxx
1x) očkovací xxxxx proti xxxxxx xxxxxxxxxx B pro xxxxx zařazené do xxxxxxxxxxxx xxxxxxxx:
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X xxxxxxxxxxxxxx 20 xxxxxxxxxx; xxxxxxxx XX04X obsahující 3-X-xxxxxx-4-xxxxxxxxxxxx-xxxxx A (XXX) 50 xxxxxxxxxx x 1 xxxxx
2. Xxxxxxxxx složení očkovacích xxxxx xxx zvláštní xxxxxxxx
2a) xxxxxxxx xxxxx proti xxxxxx xxxxxxxxxx X xx xxxxxxx xxx dospělé:
Antigenum xxxxxxxxx xxxxxxxxxxx X
2x) xxxxxxxx xxxxx xxxxx xxxxxxxxx
Virus xxxxxx xxxxxxxxxxx (xxxx Xxxxxx xxxxxx XX/XX 38&xxxx;1503-3X xxxx xxxx xxxxx 2,5 xxxxxxxxxxxxx xxxxxxxx x 1 dávce (0,5 xx)
3. Xxxxxxxxx složení xxxxxxxxxx xxxxx xxx mimořádná xxxxxxxx
3x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx A xx xxxxxxx xxx dospělé:
Xxxxxxxxx X xxxxx inactivatum
3x) xxxxxxxx xxxxx xxxxx xxxxxx hepatitidě X xx xxxxxxx xxx xxxx:
Xxxxx xxxxxxxxx X inactivatum
Xxxxxxx:
doc. XXXx. Xxxxx, CSc., x. x.
Xxxxxxxxx
Xxxxxx xxxxxxx x. 325/2011 Sb. xxxxx xxxxxxxxx xxxx 24.11.2011.
Xx xxx xxxxxxxx xxxxxx předpis xxxxx xxxxx či xxxxxxxxx.
Xxxxx xxxxxxxxxxxx xxxxxxxx xxxxx xxxxxx právních xxxxxxxx x xxxxxxxx není xxxxxxxxxxxxx, pokud xx xxxx xxxxxx xxxxxxxxx xxxxx shora xxxxxxxxx xxxxxxxx xxxxxxxx.